Hormonal and histological study on irregular genital bleeding in patients with endometriosis during treatment with dienogest, a novel progestational therapeutic agent
Authors:
Open Access
- 7 November 2007
- journal article
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 6 (4) , 223-228
Abstract
Aim: Dienogest, a novel progestational 19‐norsteroid, has been shown to have a therapeutic effect on endometriosis with its major side‐effect being irregular genital bleeding. This study aimed to investigate the mechanism responsible for the bleeding seen during dienogest therapy.Methods: For this multicenter, single‐dose, open‐label study, dienogest at a daily oral dose of 2 mg was administered for 16 weeks to nine patients with endometriosis showing regular menstrual cycles. Weekly determinations of serum endocrine hormone levels during the course of the treatment period and histological endometrial biopsies at the onset of genital bleeding were undertaken.Results: All cases showed genital bleeding irregularly during the treatment period. Endometrial histological findings at the time of presentation of the bleeding revealed a secretory, inert or atrophic appearance of the epithelium, pseudo‐decidualization in the stroma, and local hemorrhage around the regions of desquamation of epithelium and lysis in the subepithelial stromal tissue, which are characteristics of breakthrough bleeding known to occur with progestational agents. In contrast, no association with the course of genital bleeding was found with respect to changes in serum estradiol, progesterone, follicle stimulating hormone and luteinizing hormone concentrations, plasma dienogest concentration, endometrial thickness or follicular diameter.Conclusion: These results suggest that the genital bleeding seen in the period of medication with dienogest originated from breakthrough bleeding from the pseudodecidua, which reflects a direct progestational effect of dienogest on the endometrium. (Reprod Med Biol 2007; 6: 223–228)Keywords
This publication has 12 references indexed in Scilit:
- Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized studyFertility and Sterility, 2002
- The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitroMolecular Human Reproduction, 2001
- Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant usersHuman Reproduction, 2000
- Bleeding arising from the use of exogenous steroidsBest Practice & Research Clinical Obstetrics & Gynaecology, 1999
- Apoptosis, Proliferation, and Sex Hormone Receptors in Superficial Parts of Human Endometrium at the End of the Secretory Phase1The Journal of Clinical Endocrinology & Metabolism, 1999
- Apoptosis, Proliferation, and Sex Hormone Receptors in Superficial Parts of Human Endometrium at the End of the Secretory PhaseThe Journal of Clinical Endocrinology & Metabolism, 1999
- Influence of Dienogest on Ovulation in Young Fertile WomenClinical Drug Investigation, 1999
- DienogestDrugs, 1998
- Future directions for research on endometrial bleedingHuman Reproduction, 1996
- Electrochemiluminescence detection for development of immunoassays and DNA probe assays for clinical diagnosticsClinical Chemistry, 1991